← Open Payments lookup

VIGUEN MOVSESIAN: Open Payments

NPI 1477548923 · LOS ANGELES, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$693 in 12 payments from 4 companies in 2025. Trend: 2023 $411 · 2024 $112 · 2025 $693

Food & beverage: $470Education: $223
CompanyPaymentsAmount
Teva Pharmaceuticals USA, Inc.4$451
Neurocrine BioSciences, Inc.5$138
E.R. Squibb & Sons, L.L.C.2$82
Luye Pharma (USA) Ltd.1$23

Products named: UZEDY, INGREZZA, COBENFY, ERZOFRI EXTENDED-RELEASE.

Industry payments across CA — which companies pay providers there.